CDRD

Description

CDRD provides investigators with access to state-of-the-art facilities, equipment, and expertise, through six separate scientific Divisions that mirror the drug- development process — Target Validation, Screening, Medicinal Chemistry, Drug Delivery, Pharmacology/Toxicology, and Biologics. These facilities include over 35,000 square feet of translational research space on three sites at Simon Fraser University, the BC Cancer Agency, and CDRD’s new headquarters in the University of British Columbia’s new award-winning Faculty of Pharmaceutical Sciences building below.

CDRD’s headquarters in the University of British Columbia’s Pharmaceutical Sciences Building includes 35,000 sq ft of state-of-the-art drug development infrastructure and translational research space.

Ms. Es Sabar continued on to explain that while Canada is among world leaders in academic health research, there are still challenges in bringing new therapies to market. CDRD was established in 2007 to provide expertise and infrastructure to ease the transitions between discoveries and commercialization. Over six years, CDRD enterprise has established an international and national affiliated network of 40 institutions. Important to achieving CDRD’s goals, however, are the securities of a national patent protection regime, which is equally as strong as those of the trading partners.

Products & services

Similar companies nearby